A.6 INDIGO: a Global, Randomized, Double-Blinded, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Grade 2 Glioma with an IDH1/2 Mutation (Midh1/2)
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要